Lecanemab: A hope in the management of Alzheimer's disease

被引：5

作者：

Thakkar, Nandita ^{[1
]}

Martis, Preetham Basil ^{[2
]}

Kutikuppala, L. V. Simhachalam ^{[3
]}

Kuchana, Sai Kiran ^{[4
]}

Mohapatra, Ranjan K. ^{[5
]}

机构：

[1] Mahatma Gandhi Missions Inst Hlth Sci, Dept Gen Med, Navi Mumbai, Maharashtra, India

[2] Father Mullers Med Coll, Dept Gen Surg, Mangalore, Karnataka, India

[3] Dr NTR Univ Hlth Sci, Dept Gen Surg, Vijayawada 533201, Andhra Pradesh, India

[4] Kakatiya Med Coll, Dept Gen Med, Warangal, Telangana, India

[5] Govt Coll Engn, Dept Chem, Keonjhar, Odisha, India

来源：

BRAIN CIRCULATION | 2023年 / 9卷 / 03期

关键词：

D O I：

10.4103/bc.bc_10_23

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：194 / 195

页数：2

共 50 条

[21] Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease
Kurkinen, Markku
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 32 (09): : 943 - 947
[22] FDA green-lights lecanemab for Alzheimer’s disease
Chemical and Engineering News, 2023, 101 (02):
[23] Lecanemab in Alzheimer's disease: are we really facing a change in the prognosis of the disease?
Perez-Martinez, David A.
REVISTA DE NEUROLOGIA, 2023, 76 (06) : 185 - 188
[24] Food and Drug Administration Accelerated Approval of Lecanemab for Early Alzheimer's Disease-Hope, Reality, and the Unknown Going Forward
O'Malley, Patricia Anne
CLINICAL NURSE SPECIALIST, 2023, 37 (03) : 111 - 113
[25] Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data
Espay, Alberto J.
Kepp, Kasper P.
Herrup, Karl
ENEURO, 2024, 11 (07) : 1 - 6
[26] Lecanemab (Leqembi) Granted Full Approval for Early Alzheimer's Disease
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1683): : 129 - 130
[27] New Hope for Alzheimer’s Disease
B. Vellas
P. Aisen
The Journal of Prevention of Alzheimer's Disease, 2021, 8 : 238 - 239
[28] New Hope for Alzheimer's Disease
Vellas, B.
Aisen, P.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2021, 8 (03): : 238 - 239
[29] The EMA Approves Lecanemab for the Treatment of Alzheimer's Disease: The Lights and Shadows of This Decision
Bianchetti, Angelo
de Leo, Diego
GEROPSYCH-THE JOURNAL OF GERONTOPSYCHOLOGY AND GERIATRIC PSYCHIATRY, 2025,
[30] Alzheimer?s disease: FDA approves lecanemab amid cost and safety concerns
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2023, 380 : p73

← 1 2 3 4 5 →